๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

CNS involvement in Ewing's sarcoma

โœ Scribed by Yashbir Mehta; Frank R. Hendrickson


Publisher
John Wiley and Sons
Year
1974
Tongue
English
Weight
313 KB
Volume
33
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Isolated CNS involvement in Ewing sarcom
โœ Mendes, Wellington Luiz; Osorio, Carlos; de Camargo, Beatriz; Machado, Aluizio B ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 72 KB
Ewing's sarcoma
โœ Rajaram S. Iyer; S. R. Rao; A. Gurjal; Chandrika N. Nair; Suresh K. Pai; Purna A ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 424 KB

Between 1984Between -1987, 50 , 50 patients with Ewing's sarcoma of the bone were entered on combined modality protocol at Tata Memorial Hospital. Protocol treatment involved induction therapy consisting of 6-week therapy with vincristine, Adriamycin (doxorubicin), and cyclophosphamide (VDC) follow

Extraskeletal Ewing's sarcoma
โœ Rick Ahmad; Brian R. Mayol; Mary Davis; Bruce T. Rougraff ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 103 KB

## Background: Ewing's sarcoma usually is identified as a primary malignancy of bone affecting children and young adults. extraskeletal ewing's sarcoma is rare, and very few data are available addressing optimal surgical and oncologic treatment modalities. ## Methods: The authors chose to review

Periosteal Ewing's sarcoma
โœ Susan M. Bator; Thomas W. Bauer; Kenneth E. Marks; Donald G. Norris ๐Ÿ“‚ Article ๐Ÿ“… 1986 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 402 KB
Adjuvant chemotherapy in Ewing's sarcoma
โœ Dr. S. H. Advani; D. N. Rao; K. A. Dinshaw; C. N. Nair; R. Gopal; J. J. Vyas; P. ๐Ÿ“‚ Article ๐Ÿ“… 1986 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 252 KB

Adjuvant chemotherapy using vincristine, cyclophosphamide, and adriamycin was used in 28 patients with localized Ewing's sarcoma. Life-table analysis revealed 55% disease-free survival at 3 years. In contrast, our historical control showed less than 10% long-term survival. Adjuvant chemotherapy appe